journal article·2014-04

BML-111, a lipoxin receptor agonist, ameliorates ‘two-hit’-induced acute pancreatitis-associated lung injury in mice by the upregulation of heme oxygenase-1

Ying Zhen Wang, You Cheng Zhang, Jun Sheng Cheng, Qian Ni, Pei Jie Li, Shi Wen Wang, Wei Han, Yu Long Zhang

Publisher page

Abstract

The objective of this study is to investigate the effects of BML-111 on acute pancreatitis-associated lung injury (APALI) induced by cerulein with subsequent an LPS administration in mice and its possible mechanisms. One hundred and twenty-eight mice were randomly allocated to four groups, namely the APALI group, the BML-111 pretreatment group, the BM-111 control group, and the control group. The 'two-hit' mice APALI model was established by intraperitoneal injection of cerulein 7 times at hourly intervals and Escherichia coli lipopolysaccharide (LPS) once after the last dose of cerulein immediately. The samples were taken at 3, 6, 12, and 24 h after the last injection. Serum levels of amylase, TNF-a, IL-1β and IL-10, were determined. Histological score of the pancreas and lung, the wet/dry weight ratio, and heme oxygenase-1 (HO-1) expression in the lung were also evaluated. BML-111 pretreatment significantly reduced the serum levels of amylase, TNF-α, IL-1β, the wet/dry weight ratio of lung, and the pathology injury scores of pancreas and lung, and the serum levels of IL-10 were markedly increased. The severity of pancreatic and lung histology were also significantly improved by the administration of BML-111, and the expressions of HO-1 in lung tissues also increased in the BML-111 group compared with those in the APALI group. In conclusion, BML-111 exerts protective effects on APALI induced by cerulein and LPS. In addition to its anti-inflammatory effects, the beneficial effects may also be due to the upregulation of HO-1 expression in the lung tissues.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Heme Oxygenase-1 and Carbon Monoxide · Pancreatitis Pathology and Treatment · Congenital Diaphragmatic Hernia Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Bae GS · World J Gastroenterol · 2012 · 18 · 3223
2. Barreto SG · World J Emerg Surg · 2007 · 2 · 3310.1186/1749-7922-2-33 ↗
3. Barreto SG · J Indian Med Assoc · 2008 · 106 · 575
4. Bogaard HJ · Circulation · 2009 · 120 · 195110.1161/CIRCULATIONAHA.109.883843 ↗
5. Chan KH · Clin Sci (Lond) · 2011 · 120 · 49310.1042/CS20100508 ↗
6. Chen Y · Mol Cancer Ther · 2010 · 9 · 216410.1158/1535-7163.MCT-10-0173 ↗
7. Chen YP · Hepatobiliary Pancreat Dis Int · 2009 · 8 · 535
8. Chiang N · Prostaglandins Leukot Essent Fatty Acids · 2005 · 73 · 16310.1016/j.plefa.2005.05.003 ↗
9. Conte FP · Br J Pharmacol · 2010 · 161 · 91110.1111/j.1476-5381.2010.00950.x ↗
10. Copple IM · Handb Exp Pharmacol · 2010 · 233
11. DiMagno MJ · Curr Opin Gastroenterol · 2007 · 23 · 494
12. Ding SP · World J Gastroenterol · 2003 · 9 · 58410.3748/wjg.v9.i3.584 ↗
13. 10.1016/j.resp.2009.06.00810.1016/j.resp.2009.06.008 ↗
14. Elder AS · Pancreatology · 2012 · 12 · 24010.1016/j.pan.2012.03.001 ↗
15. 10.1016/j.pan.2011.12.01210.1016/j.pan.2011.12.012 ↗
16. Gong J · Resuscitation · 2012 · 83 · 90710.1016/j.resuscitation.2011.12.035 ↗
17. Gong J · Med Hypotheses · 2012 · 79 · 9210.1016/j.mehy.2012.04.010 ↗
18. 10.1016/S1359-6101(03)00059-510.1016/S1359-6101(03)00059-5 ↗
19. Hao H · Cancer Lett · 2011 · 309 · 8510.1016/j.canlet.2011.05.020 ↗
20. Hofbauer B · Gastroenterology · 1998 · 115 · 123810.1016/S0016-5085(98)70096-4 ↗
21. Immenschuh S · Histol Histopathol · 2006 · 21 · 679
22. Jung KH · J Pineal Res · 2010 · 48 · 23910.1111/j.1600-079X.2010.00748.x ↗
23. Li M · Biol Pharm Bull · 2011 · 34 · 59510.1248/bpb.34.595 ↗
24. 10.1097/MPA.0b013e318224055210.1097/MPA.0b013e3182240552 ↗
25. Nakamichi I · J Clin Invest · 2005 · 115 · 300710.1172/JCI24912 ↗
26. Otterbein LE · Trends Immunol · 2003 · 24 · 44910.1016/S1471-4906(03)00181-9 ↗
27. Pastor CM · FASEB J · 2001 · 15 · 89310.1096/fj.00-0672rev ↗
28. Pastor CM · Chest · 2003 · 124 · 234110.1378/chest.124.6.2341 ↗
29. 10.2174/09298670677852201110.2174/092986706778522011 ↗
30. 10.1097/00000658-199201000-0000710.1097/00000658-199201000-00007 ↗
31. Seo SW · Int J Mol Med · 2011 · 27 · 53
32. Shen HN · Pancreas · 2011 · 40 · 1010.1097/MPA.0b013e3181f7e750 ↗
33. Steer ML · Respir Physiol · 2001 · 128 · 1310.1016/S0034-5687(01)00259-6 ↗
34. Wang M · Cell Death Differ · 2010 · 17 · 48810.1038/cdd.2009.144 ↗
35. Wang X · Pancreas · 2010 · 39 · 11410.1097/MPA.0b013e3181b65dd5 ↗
36. Weis S · PLOS ONE · 2012 · 7 · 3798110.1371/journal.pone.0037981 ↗
37. Yang R · J Surg Res · 2009 · 153 · 30210.1016/j.jss.2008.04.004 ↗
38. 10.1111/j.1872-034X.2007.00154.x10.1111/j.1872-034X.2007.00154.x ↗
39. Zhang L · Inflamm Res · 2008 · 57 · 15710.1007/s00011-007-7141-z ↗
40. Zhou M · Scand J Gastroenterol · 2011 · 46 · 21110.3109/00365521.2010.525715 ↗